| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 02/25/2004 | EP1390664A1 Materials, methods, and uses for photochemical generation of acids and/or radical species |
| 02/25/2004 | EP1390357A2 Anti-thrombotic compounds, production and use thereof as medicaments |
| 02/25/2004 | EP1390341A1 N-benzyl-m-phenylenediamine derivatives and dyes containing said compounds |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1230232B1 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/25/2004 | EP1165497B1 Method of preparing granular n-alkyl-ammonium acetonitrile salts |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | EP1140807B1 Method for preparing nitroxides |
| 02/25/2004 | EP1135369B1 Alpha-sulfin- and alpha-sulfonamino acid amides |
| 02/25/2004 | EP1087934B1 Aminocyclohexyl ether compounds and uses thereof |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | EP0883405B1 Amidino protease inhibitors |
| 02/25/2004 | CN1478076A MCH antagonists and their use in treatment of obesity |
| 02/25/2004 | CN1478074A Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/25/2004 | CN1478072A Tetralone derivatives as antitumor agents |
| 02/25/2004 | CN1139582C Process for extracting N-methyl morpholine and N-ethyl morpholine in morpholine waste water |
| 02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
| 02/24/2004 | US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696450 Serotonergic agents with long-acting in vivo effects |
| 02/24/2004 | US6696449 Control degradation of conencting tissue; cardiovascular disorders |
| 02/24/2004 | US6696447 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014825A1 Cannabinoid receptor ligands |
| 02/19/2004 | WO2003065989A3 (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 02/19/2004 | US20040034242 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
| 02/19/2004 | US20040034104 2,2-Diphenylbutanamide derivatives and medicines containing the same |
| 02/19/2004 | US20040034103 Cdc25 photophatase inhibitors |
| 02/19/2004 | US20040034080 Comprises catalytic hydroformylation/hydrocarbonylation and reductive amination using a transition metal catalyst |
| 02/19/2004 | US20040034072 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/19/2004 | US20040034071 An enzyme inhibitor for matrix metalloprotease |
| 02/19/2004 | US20040034070 Propanolaminotetralines, preparation thereof and compositions containing same |
| 02/19/2004 | US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 02/19/2004 | US20040034036 A serotonin 6 (5-HT6) receptor antagonist useful in the treatment of CNS disorders; oral bioavailability; Alzheimers disease; cognitive activators; attention deficit disorder; antidepressants; anxiolytic agents; headaches; hyperactivity |
| 02/19/2004 | US20040034035 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 02/19/2004 | US20040034034 Novel piperazine derivatives |
| 02/19/2004 | US20040034011 Administering to a mammal a napthalene derivative containing at least two hydroxy groups at ortho position to one another, for the treatment of disorders caused by catechol-O-methyltransferase enzyme |
| 02/19/2004 | US20040033986 Anti tubercular drug: compositions and methods |
| 02/19/2004 | CA2494827A1 Cannabinoid receptor ligands |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1389611A1 20-hydroxyeicosatetraenoic acid production inhibitors |
| 02/18/2004 | EP1389194A2 Inhibitors of bace |
| 02/18/2004 | EP1389193A1 Method for producing biperiden i |
| 02/18/2004 | EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 02/18/2004 | EP1389188A1 Method for the production of biperiden ii |
| 02/18/2004 | EP1292572B1 Propanolaminotetralines, preparation thereof and compositions containing same |
| 02/18/2004 | EP1286953B1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
| 02/18/2004 | EP1169301B1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 02/18/2004 | EP1036070B1 N-alkyl ammonium acetonitrile salts, methods therefor and compositions therewith |
| 02/18/2004 | EP0980351B1 Benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments |
| 02/18/2004 | EP0946166B1 Use of matrix metalloproteinase inhibitors for promoting wound healing |
| 02/18/2004 | EP0839134B1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| 02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
| 02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 02/17/2004 | US6693202 Multibinding ligands containing such as amine, amide, ester, hydroxyl, carbamate, urea and/or imino functionality |
| 02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
| 02/17/2004 | US6693137 Sulphonamide derivatives |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/17/2004 | US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol |
| 02/17/2004 | US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| 02/17/2004 | US6693095 7-(((5-amino-1,2,4-thiadiazol-3-yl)-(z)-(fluormethoxyimino) -acetyl)amino)-3(e)-((imino-1-piperazinylmethyl)-methylhydrazono)methyl-3 -cephem-4-carboxylic acid trihydrochloride for example |
| 02/17/2004 | CA2124680C Piperazine derivatives as 5-ht1a antagonists |
| 02/12/2004 | WO2004013128A1 Novel substituted benzamides production and use thereof as medicaments |
| 02/12/2004 | WO2004013115A2 Carboxamides, production and use thereof as medicaments____ |
| 02/12/2004 | WO2004013114A1 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers |
| 02/12/2004 | WO2003095437A8 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent |
| 02/12/2004 | WO2003017948A3 Aryl tetrahydronaphthalene derivatives |
| 02/12/2004 | WO2002100344A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 02/12/2004 | US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects |
| 02/12/2004 | US20040030131 Central nervous system disorders |
| 02/12/2004 | US20040030129 NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient |
| 02/12/2004 | US20040029928 Tumor necrosis factor alpha-converting enzyme inhibitor; rheumatic diseases; antiarthritic agents; infections; autoimmune diseases; antidiabetic agents |
| 02/12/2004 | US20040029895 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 02/12/2004 | US20040029894 Nootropic effect enhancer |
| 02/12/2004 | US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders |
| 02/12/2004 | US20040029887 Cardiovascular disorders; antiinflammatory agents; central nervous system diosrders; psychological disorders |
| 02/12/2004 | US20040029876 Acylamino cyclopropane derivatives |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029854 Nirtic oxide donors based on metallic centres |
| 02/12/2004 | US20040029838 Anticancer agents |
| 02/12/2004 | US20040029814 Cathepins inhibitor; antiinflammatory agents; antiarthritic agents |
| 02/12/2004 | CA2493551A1 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers |
| 02/11/2004 | EP1388538A1 Polymerisation Initiator |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388529A2 Stable ethylene inhibiting compounds and methods for their preparation |
| 02/11/2004 | EP1387831A1 Substituted arylketones |
| 02/11/2004 | EP1387829A1 Novel pyridinone and related heterocyclic derivatives |
| 02/11/2004 | EP1387828A2 Method for producing biperiden iv |
| 02/11/2004 | EP1387821A2 Estrogen receptor modulators |
| 02/11/2004 | EP1299356B1 Novel compounds |
| 02/11/2004 | EP1003373B1 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 02/11/2004 | CN1474862A Fluorinated-photoinitiators in dual cure resins |
| 02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
| 02/11/2004 | CN1474689A CDC25 phosphatase inhibitors |
| 02/11/2004 | CN1473831A Process for preparing pyrazolo (4,3-d) pyrimidine-7-ketone and its intermediate |
| 02/11/2004 | CN1473820A Process for preparing naftopidil |